Researchers have uncovered a new way to attack lymphoma by targeting a non-catalytic region of a key regulatory enzyme, rather than its traditional active site. Researchers at VCU Massey Comprehensive Cancer Center found a surprising new angle for fighting lymphoma using a medication that is already approved for abnormal heart rhythms. Instead of treating cancer […]Health,Blood,Cancer,Immunology,Oncology,Virginia Commonwealth University#Heart #Medication #Unlock #NonToxic #Cancer #Treatment #Strategy1771478633
